Singular Genomics Systems has unveiled its Max Read Kits, designed to maximise throughput and reduce costs for single cell experiments.
Run on the company’s G4 Sequencing Platform, the Max Read Kits for single-cell applications have been launched at the Advances in Genome Biology and Technology (AGBT) 23rd General Meeting, currently taking place in Florida, US.
The Max Read Kits are designed to match the format of 10x Genomics assays and expected to boost the G4’s potential output to 3.2 billion reads per run on a single cell sequencing benchtop system.
This would provide users with the flexibility to sequence four, eight, 12 or 16 samples per run, with each in its own lane.
The company is planning to price the sequencing kits at $1 per million reads. It will provide 800 million reads per flow cell with an 80%-90% Q30 quality.
Singular Genomics chairman and CEO Drew Spaventa said: “We believe the combination of speed, flexibility, cost and power that the Max Read Kits provide will firmly establish the G4 as the leading benchtop system for customers running single cell applications.
“We look forward to sharing data at AGBT and to begin shipping to our customers in the second quarter of this year.”
Quality specifications for the G4 platform, including the F2 and F3 flow cells, have also been increased to 80%-90% Q30 quality.
Furthermore, the company increased the throughput range of the F2 and F3 cells to up to 250 million and up to 450 million reads, respectively.
Spaventa added: “We have seen consistent improvement on the throughput of our flow cells and, for certain applications, we are now achieving up to 1.8 billion reads per run on the F3 flow cells.
“We’ve been especially pleased with the quality of data coming from our F3 flow cells and are excited to start sending these to select customers later this month.”